0455.HK - Tianda Pharmaceuticals Limited

HKSE - HKSE Delayed Price. Currency in HKD

Tianda Pharmaceuticals Limited

Suites 2405-2410 24th Floor No. 1 Tim Mei Avenue
Hong Kong
852 2545 3313

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees562

Key Executives

NameTitlePayExercisedYear Born
Mr. Wen Quan FangChairman & MD60kN/A1969
Mr. Man Sang LuiExec. Director72kN/A1964
Ms. Wendy WuChief Financial OfficerN/AN/AN/A
Mr. Tai On Lo CPA, CPACompany Sec.N/AN/A1954
Mr. Man Yuk WongFinancial ControllerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.


Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese and western medicines and biochemical drugs, etc., such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, detoxification agents, and other pharmaceutical products; and health care products comprising bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women's nutrition, wellbeing, personal care, and honey products. The company offers its health care products under the Herb Valley brand name. It also engages in sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; and property holding business. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Corporate Governance

Tianda Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.